NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

GSP Crop Science IPO Update

As of the second day of bidding, the initial public offering (IPO) of GSP Crop Science has received a subscription of 65%. According to data from the NSE, the company received bids for 58.25 lakh shares against the 89.47 lakh shares on offer, up to 12:35 pm.

The subscription trend is as follows:

  • QIBs category received 1.28 times subscription
  • Non-institutional investors' portion fetched 1 times subscription
  • Retail Individual Investors (RIIs) quota attracted only 15% subscription

The company's Rs 400-crore initial share sale will conclude on March 18, with a price band of Rs 304-320 per share, valuing the company at Rs 1,489 crore at the higher end.

Read also: SMR Jewels IPO Successfully Lists with Institutional Support

GSP Crop Science, a research-focused agrochemical company with over 39 years of expertise, aims to raise Rs 170 crore from the IPO, which will be used for debt payment and general corporate purposes.

The allotment of shares is expected by March 20, while the share listing is proposed to take place on March 24.

Investor Takeaway

GSP Crop Science's IPO has seen a 65% subscription on Day 2, indicating strong interest from investors.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.